risk management
risk management
03/21/2022
Catch up on the latest COVID-19 news in this week’s roundup! Coverage includes the efficacy and safety of sotrovimab as a COVID-19 treatment, recommendations on the management of myocardial sequelae,...
03/21/2022
Multiple Sclerosis
Multiple Sclerosis
05/07/2020
In a recent study, researchers investigated whether women with multiple sclerosis have an increased risk of relapse after pregnancy, and whether this risk is impacted by breastfeeding or disease-modifying...
05/07/2020
Multiple Sclerosis
Multiple Sclerosis
05/07/2020
In a recent study, researchers investigated whether women with multiple sclerosis have an increased risk of relapse after pregnancy, and whether this risk is impacted by breastfeeding or disease-modifying...
05/07/2020
Treatment
Treatment
03/04/2020
After identifying 3 neuroprotective drugs acting on different axonal pathobiologies, the researchers assessed each drug’s efficacy on percentage brain volume change among patients with secondary progressive...
03/04/2020
bone density
bone density
02/14/2020
It is unclear why patients with multiple sclerosis have reduced bone mineral density. Authors of a new study investigated the factors that may cause this decrease and found several independent contributors....
02/14/2020
Screening
Screening
12/17/2019
For this study, the researchers evaluated whether magnetoencephalography scanning could be a valuable measure of cognitive impairment among patients with multiple sclerosis. Their findings might surprise...
12/17/2019
FDA
FDA
12/06/2019
Three applications for the first generic capsules have been granted by the US Food and Drug Administration.
12/06/2019
Multiple Sclerosis
Multiple Sclerosis
11/22/2019
The RADIANCE phase 2 study showed the effectiveness of an investigational MS therapy vs placebo, so authors of the phase 3 SUNBEAM study compared the drug’s efficacy and safety with that of intramuscular...
11/22/2019
Multiple Sclerosis
Multiple Sclerosis
11/22/2019
The RADIANCE phase 2 study showed the effectiveness of an investigational MS therapy vs placebo, so authors of the phase 3 SUNBEAM study compared the drug’s efficacy and safety with that of intramuscular...
11/22/2019
pregnancy
pregnancy
09/10/2019
Authors of a new study analyzed whether an offspring’s risk of multiple sclerosis is impacted by the maternal Epstein–Barr virus IgG antibody levels.
09/10/2019